UG Healthcare Corporation Limited (SGX:8K7)

UG Healthcare Corporation Income Statement

Financials in millions SGD. Fiscal year is July - June.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021
Revenue	144.07	115.21	101.13	232.6	338.4
Revenue Growth (YoY)	25.06%	13.91%	-56.52%	-31.27%	134.66%
Cost of Revenue	109.34	89.34	99.69	148.21	142.24
Gross Profit	34.74	25.87	1.45	84.39	196.16
Selling, General & Admin	35.55	32.49	26.57	33.22	40.37
Operating Expenses	35.55	32.49	26.57	33.22	40.37
Operating Income	-0.82	-6.63	-25.12	51.17	155.79
Interest Expense	-2.19	-1.28	-0.92	-0.81	-0.6
Interest & Investment Income	0.79	2.01	2.15	0.43	0.11
Earnings From Equity Investments	-0.04	-0.08	0.56	0.1	3.58
Currency Exchange Gain (Loss)	-0.08	-3.06	0.37	-	0.99
Other Non Operating Income (Expenses)	0.36	2.04	-0.08	-2.15	-0.46
EBT Excluding Unusual Items	-1.96	-6.99	-23.03	48.74	159.4
Impairment of Goodwill	-1	-	-	-	-
Gain (Loss) on Sale of Assets	-	-	-	0.02	-
Asset Writedown	-0.78	-	-5.33	-	-
Pretax Income	-3.74	-6.99	-28.36	48.76	159.4
Income Tax Expense	0.98	-0.31	-1.4	8.96	39.46
Earnings From Continuing Operations	-4.72	-6.68	-26.96	39.8	119.94
Minority Interest in Earnings	0.63	2.73	6.23	-3	-1.18
Net Income	-4.1	-3.96	-20.73	36.8	118.77
Net Income to Common	-4.1	-3.96	-20.73	36.8	118.77
Net Income Growth	-	-	-	-69.02%	786.17%
Shares Outstanding (Basic)	624	624	624	620	611
Shares Outstanding (Diluted)	624	624	624	620	611
Shares Change (YoY)	-	-	0.58%	1.43%	3.24%
EPS (Basic)	-0.01	-0.01	-0.03	0.06	0.19
EPS (Diluted)	-0.01	-0.01	-0.03	0.06	0.19
EPS Growth	-	-	-	-69.45%	759.42%
Free Cash Flow	-6.05	-11.1	-44.7	33.21	63.19
Free Cash Flow Per Share	-0.01	-0.02	-0.07	0.05	0.10
Dividend Per Share	-	-	-	0.003	0.004
Dividend Growth	-	-	-	-21.18%	70.59%
Gross Margin	24.11%	22.45%	1.43%	36.28%	57.97%
Operating Margin	-0.57%	-5.75%	-24.84%	22.00%	46.04%
Profit Margin	-2.84%	-3.44%	-20.50%	15.82%	35.10%
Free Cash Flow Margin	-4.20%	-9.63%	-44.20%	14.28%	18.67%
EBITDA	2.3	-3.45	-22.41	54.21	158.28
EBITDA Margin	1.60%	-3.00%	-22.16%	23.31%	46.77%
D&A For EBITDA	3.12	3.18	2.71	3.05	2.49
EBIT	-0.82	-6.63	-25.12	51.17	155.79
EBIT Margin	-0.57%	-5.75%	-24.84%	22.00%	46.04%
Effective Tax Rate	-	-	-	18.38%	24.75%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.